(Q45047703)

8 December 2017

title

The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours (English)

1 reference

8 December 2017

The long‐term outcome of patients who relapse after chemotherapy for non‐seminomatous germ cell tumours (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

16 May 2024

author name string

J. A. Ledermann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

L. Holden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

E. S. Newlands

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

R. H. Begent

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

G. J. Rustin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

K. D. Bagshawe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

M. Brampton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522874

16 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522874

16 May 2024

publication date

1 August 1994

1 reference

full work available at URL

8 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.1994.tb16591.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1994.tb16591.x/fullpdf

16 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

British Journal of Urology

16 May 2024

published in

1 reference

8 December 2017

volume

74

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

225-230

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1994.TB16591.X

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1994.TB16591.X

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1994.TB16591.X

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1994.TB16591.X

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

16 May 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.

16 May 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Ifosfamide in refractory male germ cell tumors

16 May 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group

16 May 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

16 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)

16 May 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas

16 May 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Current optimum management of anaplastic germ cell tumours of the testis and other sites

16 May 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Nonparametric Estimation from Incomplete Observations

16 May 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

A computer program for comparing K samples with right-censored data

16 May 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours

16 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

16 May 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

16 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions

16 May 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1994.TB16591.X

16 May 2024

Identifiers

1 reference

8 December 2017

1 reference